In this model, the crucial role of Itga4 in the pathology of GVHD38,39 offers inhibition of Itga4 in allo-reactive T cell migration to peripheral tissues as a therapeutic approach for GVHD. This evidence concerns the gene ITGA4 and graft versus host disease.